Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Pulmonary Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.9% during the forecast period.
This report presents the market size and development trends by detailing the Pulmonary Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pulmonary Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pulmonary Drugs industry and will help you to build a panoramic view of the industrial development.
Pulmonary Drugs Market, By Type:
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
Pulmonary Drugs Market, By Application:
Asthma & COP
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Some of the leading players are as follows:
Bayer AG
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca plc
Teva Pharmaceutical Industries Lt
Sunovion Pharmaceuticals
Novartis AG
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Pulmonary Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 Inhaled Corticosteroids (ICS)
-
1.3.2 Long-Acting Beta2-Agonists (LABA)
-
1.3.3 Antihistamine
-
1.3.4 Vasodilators
-
1.3.5 Short-Acting Beta2-Agonists (SABA)
-
1.3.6 Anticholinergics
-
1.3.7 Combination Drugs
-
1.3.8 MAbs
-
1.3.9 Enzymes
-
1.3.10 Antibiotics & Antileukotrienes
-
1.4 Market Segment by Application
-
1.4.1 Asthma & COP
-
1.4.2 Allergic Rhinitis
-
1.4.3 Pulmonary Arterial Hypertension
-
1.4.4 Cystic Fibrosis
-
1.5 Market Segment by Regions
-
1.5.1 North America Pulmonary Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Pulmonary Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Pulmonary Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 LAMEA Pulmonary Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Pulmonary Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Pulmonary Drugs by Major Types
-
3.4.1 Inhaled Corticosteroids (ICS)
-
3.4.2 Long-Acting Beta2-Agonists (LABA)
-
3.4.3 Antihistamine
-
3.4.4 Vasodilators
-
3.4.5 Short-Acting Beta2-Agonists (SABA)
-
3.4.6 Anticholinergics
-
3.4.7 Combination Drugs
-
3.4.8 MAbs
-
3.4.9 Enzymes
-
3.4.10 Antibiotics & Antileukotrienes
4 Segmentation of Pulmonary Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Pulmonary Drugs by Major End-Users
-
4.4.1 Asthma & COP
-
4.4.2 Allergic Rhinitis
-
4.4.3 Pulmonary Arterial Hypertension
-
4.4.4 Cystic Fibrosis
5 Market Analysis by Major Regions
-
5.1 Global Pulmonary Drugs Production Analysis by Top Regions
-
5.2 Global Pulmonary Drugs Consumption Analysis by Top Regions
-
5.3 Global Pulmonary Drugs Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
5.3.4 LAMEA Pulmonary Drugs Production, Import, Consumption and Export Analysis
6 Product Circulation of Pulmonary Drugs Market among Top Countries
-
6.1 Top 5 Export Countries in Pulmonary Drugs Market from 2014 to 2019
-
6.1.1 Top 5 Export Countries’ Export Value Analysis in Pulmonary Drugs Market from 2014 to 2019
-
6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pulmonary Drugs Market from 2014 to 2019
-
6.2 Top 5 Import Countries in Pulmonary Drugs Market from 2014 to 2019
-
6.2.1 Top 5 Import Countries’ Import Value Analysis in Pulmonary Drugs Market from 2014 to 2019
-
6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pulmonary Drugs Market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7. North America Pulmonary Drugs Landscape Analysis
-
7.1 North America Pulmonary Drugs Landscape Analysis by Top Countries
-
7.1.1 United States Pulmonary Drugs Market Volume and Growth Rate
-
7.1.2 Canada Pulmonary Drugs Market Volume and Growth Rate
-
7.1.3 Mexico Pulmonary Drugs Market Volume and Growth Rate
8. Europe Pulmonary Drugs Landscape Analysis
-
8.1 Europe Pulmonary Drugs Landscape Analysis by Major Types
-
8.2 Europe Pulmonary Drugs Landscape Analysis by Major End-Users
-
8.3 Europe Pulmonary Drugs Landscape Analysis by Top Countries
-
8.3.1 Germany Pulmonary Drugs Market Volume and Growth Rate
-
8.3.2 UK Pulmonary Drugs Market Volume and Growth Rate
-
8.3.3 France Pulmonary Drugs Market Volume and Growth Rate
-
8.3.4 Italy Pulmonary Drugs Market Volume and Growth Rate
-
8.3.5 Spain Pulmonary Drugs Market Volume and Growth Rate
-
8.3.6 Belgium Pulmonary Drugs Market Volume and Growth Rate
-
8.3.7 Poland Pulmonary Drugs Market Volume and Growth Rate
-
8.3.8 Russia Pulmonary Drugs Market Volume and Growth Rate
-
8.3.9 Turkey Pulmonary Drugs Market Volume and Growth Rate
-
8.3.10 Netherlands Pulmonary Drugs Market Volume and Growth Rate
-
8.3.11 Portugal Pulmonary Drugs Market Volume and Growth Rate
-
8.3.12 Denmark Pulmonary Drugs Market Volume and Growth Rate
-
8.3.13 Finland Pulmonary Drugs Market Volume and Growth Rate
-
8.3.14 Iceland Pulmonary Drugs Market Volume and Growth Rate
-
8.3.15 Norway Pulmonary Drugs Market Volume and Growth Rate
-
8.3.16 Sweden Pulmonary Drugs Market Volume and Growth Rate
-
8.4 Top 3 Players Profiles in Europe
9 Asia Pacific Pulmonary Drugs Landscape Analysis
-
9.1 Asia Pacific Pulmonary Drugs Landscape Analysis by Top Countries
-
9.1.1 China Pulmonary Drugs Market Volume and Growth Rate
-
9.1.2 Japan Pulmonary Drugs Market Volume and Growth Rate
-
9.1.3 Australia and New Zealand (ANZ) Pulmonary Drugs Market Volume and Growth Rate
-
9.1.4 India Pulmonary Drugs Market Volume and Growth Rate
-
9.1.5 ASEAN Pulmonary Drugs Market Volume and Growth Rate
-
9.1.6 South Korea Pulmonary Drugs Market Volume and Growth Rate
10 LAMEA Pulmonary Drugs Landscape Analysis
-
10.1 LAMEA Pulmonary Drugs Landscape Analysis by Top Countries
-
10.1.1 GCC Countries Pulmonary Drugs Market Volume and Growth Rate
-
10.1.2 Brazil Pulmonary Drugs Market Volume and Growth Rate
-
10.1.3 North Africa Pulmonary Drugs Market Volume and Growth Rate
-
10.1.4 South Africa Pulmonary Drugs Market Volume and Growth Rate
-
10.1.5 Argentina Pulmonary Drugs Market Volume and Growth Rate
11 Major Players Profiles
-
11.1 Bayer AG
-
11.1.1 Bayer AG Company Profile and Recent Development
-
11.1.2 Market Performance
-
11.1.3 Product and Service Introduction
-
11.2 GlaxoSmithKline plc
-
11.2.1 GlaxoSmithKline plc Company Profile and Recent Development
-
11.2.2 Market Performance
-
11.2.3 Product and Service Introduction
-
11.3 Boehringer Ingelheim GmbH
-
11.3.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
-
11.3.2 Market Performance
-
11.3.3 Product and Service Introduction
-
11.4 AstraZeneca plc
-
11.4.1 AstraZeneca plc Company Profile and Recent Development
-
11.4.2 Market Performance
-
11.4.3 Product and Service Introduction
-
11.5 Teva Pharmaceutical Industries Lt
-
11.5.1 Teva Pharmaceutical Industries Lt Company Profile and Recent Development
-
11.5.2 Market Performance
-
11.5.3 Product and Service Introduction
-
11.6 Sunovion Pharmaceuticals
-
11.6.1 Sunovion Pharmaceuticals Company Profile and Recent Development
-
11.6.2 Market Performance
-
11.6.3 Product and Service Introduction
-
11.7 Novartis AG
-
11.7.1 Novartis AG Company Profile and Recent Development
-
11.7.2 Market Performance
-
11.7.3 Product and Service Introduction
The List of Tables and Figures (Totals 107 Figures and 181 Tables)
-
Figure Product Picture
-
Figure Market Size and Growth Rate of Inhaled Corticosteroids (ICS)
-
Figure Market Size and Growth Rate of Long-Acting Beta2-Agonists (LABA)
-
Figure Market Size and Growth Rate of Antihistamine
-
Figure Market Size and Growth Rate of Vasodilators
-
Figure Market Size and Growth Rate of Short-Acting Beta2-Agonists (SABA)
-
Figure Market Size and Growth Rate of Anticholinergics
-
Figure Market Size and Growth Rate of Combination Drugs
-
Figure Market Size and Growth Rate of MAbs
-
Figure Market Size and Growth Rate of Enzymes
-
Figure Market Size and Growth Rate of Antibiotics & Antileukotrienes
-
Figure Market Size and Growth Rate of Asthma & COP
-
Figure Market Size and Growth Rate of Allergic Rhinitis
-
Figure Market Size and Growth Rate of Pulmonary Arterial Hypertension
-
Figure Market Size and Growth Rate of Cystic Fibrosis
-
Figure North America Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure United States Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure UK Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure France Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure China Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Australia Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure India Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure LAMEA Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure North Africa Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Pulmonary Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Pulmonary Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Pulmonary Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Pulmonary Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Pulmonary Drugs by Different Types from 2014 to 2026
-
Figure Market Size and Growth Rate of Inhaled Corticosteroids (ICS)
-
Figure Market Size and Growth Rate of Long-Acting Beta2-Agonists (LABA)
-
Figure Market Size and Growth Rate of Antihistamine
-
Figure Market Size and Growth Rate of Vasodilators
-
Figure Market Size and Growth Rate of Short-Acting Beta2-Agonists (SABA)
-
Figure Market Size and Growth Rate of Anticholinergics
-
Figure Market Size and Growth Rate of Combination Drugs
-
Figure Market Size and Growth Rate of MAbs
-
Figure Market Size and Growth Rate of Enzymes
-
Figure Market Size and Growth Rate of Antibiotics & Antileukotrienes
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Pulmonary Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Pulmonary Drugs by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Asthma & COP
-
Figure Market Size and Growth Rate of Allergic Rhinitis
-
Figure Market Size and Growth Rate of Pulmonary Arterial Hypertension
-
Figure Market Size and Growth Rate of Cystic Fibrosis
-
Table Global Pulmonary Drugs Production by Major Regions
-
Table Global Pulmonary Drugs Production Share by Major Regions
-
Table Global Pulmonary Drugs Consumption by Major Regions
-
Table Global Pulmonary Drugs Consumption Share by Major Regions
-
Table North America Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
Table Europe Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
Table LAMEA Pulmonary Drugs Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Pulmonary Drugs Market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Pulmonary Drugs Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Pulmonary Drugs Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Pulmonary Drugs Market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Pulmonary Drugs Consumption by Major Countries from 2014 to 2026
-
Table North America Pulmonary Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Pulmonary Drugs Consumption Share by Major Countries in 2014
-
Figure North America Pulmonary Drugs Consumption Share by Major Countries in 2018
-
Figure North America Pulmonary Drugs Consumption Share by Major Countries in 2026
-
Figure United States Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Pulmonary Drugs Consumption by Types from 2014 to 2026
-
Table Europe Pulmonary Drugs Consumption Share by Types from 2014 to 2026
-
Table Europe Pulmonary Drugs Consumption by End-Users from 2014 to 2026
-
Table Europe Pulmonary Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Europe Pulmonary Drugs Consumption by Major Countries from 2014 to 2026
-
Table Europe Pulmonary Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure Germany Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure France Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Spain Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Netherlands Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Portugal Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Denmark Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Finland Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Iceland Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Norway Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Sweden Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Pulmonary Drugs Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Pulmonary Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure China Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure India Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Pulmonary Drugs Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Pulmonary Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure GCC Countries Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Countries Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure North Africa Countries Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Countries Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Countries Pulmonary Drugs Market Volume and Growth Rate from 2014 to 2026
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc
-
Figure Sales and Growth Rate Analysis of AstraZeneca plc
-
Figure Revenue and Market Share Analysis of AstraZeneca plc
-
Table Product and Service Introduction of AstraZeneca plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Lt
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Lt
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Lt
-
Table Product and Service Introduction of Teva Pharmaceutical Industries Lt
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sunovion Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Sunovion Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Sunovion Pharmaceuticals
-
Table Product and Service Introduction of Sunovion Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
